CONMED Corp.

CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The company's product lines consist of orthopedic surgery, which consists of sports medicine instrumentation and small bone, large bone and specialty powered surgical instruments, as well as imaging systems for use in minimally invasive surgery procedures and service fees related to the promotion and marketing of sports medicine allograft tissue; and general surgery, which consists of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, cardiac monitoring products as well as electrosurgical generators and related instruments.
  • TickerCNMD
  • ISINUS2074101013
  • ExchangeNew York Stock Exchange
  • SectorHealth Care Equipment & Services
  • CountryUnited States

Conmed Corp: 1 director

A director at Conmed Corp sold 42,347 shares at 132.087USD and the significance rating of the trade was 80/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board m...

An increasingly favourable environment allows CONMED to improve to Neutral

The independent financial analyst theScreener just upgraded the general evaluation of CONMED (US), a company active in the Medical Equipment industry. As regards its fundamental valuation, the title confirms its rating of 3 out of 4 stars while its market behaviour remains as risky. theScreener believes, however, that a more enabling environment allows the title to increase its general evaluation to Neutral. As of the analysis date December 29, 2020, the closing price was USD 112.09 and its expected value was estimated at USD 100.23.

MarketLine Department

Boston Scientific Corporation - Strategy, SWOT and Corporate Finance Report

Summary Boston Scientific Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Boston Scientific Corporation (Boston Scientific) is a manufacturer of medical devices used in interventional medical specialties. The company's solutions include drug-eluting coronary stent systems, percutaneous coronary interventions (PCI), intravascular catheter-directed ult...

MarketLine Department

Stryker Corporation - Strategy, SWOT and Corporate Finance Report

Summary Stryker Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Stryker Corporation (Stryker or 'the company') is a medical technology company, which offers a diverse array of innovative products and services in orthopaedics, medical and surgical, neurotechnology and spine products. The major product portfolio of the company includes surgical equipme...

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • A few Consumer Discretionary names continue to act well. The list is thinning of attractive names though. (ex. FOXF, UEIC, DECK, CHDN, WING, YUM, BOOT, RCI, POOL, DLTR, and AAN) • A number of Health Care Sector names are attractive. (ex. MASI, TFX, CNMD, STE, CRVL, LNTH, HAE, COO, WST, RGEN, ANIK, NEO, and TECH) • Attractive Technology and Services names include: MANH, CDNS, ANSS, AGYS, TTEC, CLGX, MMS, and KBR

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • Health Care Equipment & Supplies remains a leadership area in the Health Care Sector. • A number of Biotechnology stocks are making major reversals with many hitting 52-week RS highs. • Semiconductors, Semi-Suppliers, and Electronic Components remain as leadership Groups.

Dave Nicoski ...
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Breadth indicators mostly positive; Energy surging While defensive sectors continue to lag, one cyclical sector, Energy, has surged to the top of our relative strength rankings. Though we continue to expect further consolidation and volatility, current sector leadership and mostly positive breadth indicators point to a risk-on environment. Bottom line: the 200-day moving average and prior lows on the S&P 500 need to continue holding as support for us to remain constructive. • Breadth indicators mostly positive. Whether cap- or equal-weighted, Discretionary vs. Staples ratios remain favor...

Conmed Corp: 1 director

A director at Conmed Corp sold 42,347 shares at 132.087USD and the significance rating of the trade was 80/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board m...

MarketLine Department

Boston Scientific Corporation - Strategy, SWOT and Corporate Finance Report

Summary Boston Scientific Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Boston Scientific Corporation (Boston Scientific) is a manufacturer of medical devices used in interventional medical specialties. The company's solutions include drug-eluting coronary stent systems, percutaneous coronary interventions (PCI), intravascular catheter-directed ult...

MarketLine Department

Stryker Corporation - Strategy, SWOT and Corporate Finance Report

Summary Stryker Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Stryker Corporation (Stryker or 'the company') is a medical technology company, which offers a diverse array of innovative products and services in orthopaedics, medical and surgical, neurotechnology and spine products. The major product portfolio of the company includes surgical equipme...

MarketLine Department

Stryker Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances And Investments

Summary Marketline's Stryker Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Stryker Corporation since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage....

MarketLine Department

Boston Scientific Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances And Investments

Summary Marketline's Boston Scientific Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Boston Scientific Corp since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive adva...

An increasingly favourable environment allows CONMED to improve to Neutral

The independent financial analyst theScreener just upgraded the general evaluation of CONMED (US), a company active in the Medical Equipment industry. As regards its fundamental valuation, the title confirms its rating of 3 out of 4 stars while its market behaviour remains as risky. theScreener believes, however, that a more enabling environment allows the title to increase its general evaluation to Neutral. As of the analysis date December 29, 2020, the closing price was USD 112.09 and its expected value was estimated at USD 100.23.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch